Ondansetron Treatment in a Child Presenting with Chronic Intractable Pruritus
The case of a seven-year-old boy with chronic pruritus secondary to a giant congenital melanocytic nevus is presented. The pruritus did not respond to conventional antipruritic drug treatment, but responded to ondansetron, a selective antagonist of 5-hydroxytryptamine type 3 receptors.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2006-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/2006/873870 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832553332614365184 |
|---|---|
| author | Chantal Frigon Joëlle Desparmet |
| author_facet | Chantal Frigon Joëlle Desparmet |
| author_sort | Chantal Frigon |
| collection | DOAJ |
| description | The case of a seven-year-old boy with chronic pruritus secondary to a giant congenital melanocytic nevus is presented. The pruritus did not respond to conventional antipruritic drug treatment, but responded to ondansetron, a selective antagonist of 5-hydroxytryptamine type 3 receptors. |
| format | Article |
| id | doaj-art-68791ae7ac5044788997b284cec931e1 |
| institution | Kabale University |
| issn | 1203-6765 |
| language | English |
| publishDate | 2006-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Pain Research and Management |
| spelling | doaj-art-68791ae7ac5044788997b284cec931e12025-02-03T05:54:14ZengWileyPain Research and Management1203-67652006-01-0111424524710.1155/2006/873870Ondansetron Treatment in a Child Presenting with Chronic Intractable PruritusChantal Frigon0Joëlle Desparmet1Chronic Pain Clinic, Department of Anesthesia, The Montreal Children’s Hospital, Montreal, Quebec, CanadaChronic Pain Clinic, Department of Anesthesia, The Montreal Children’s Hospital, Montreal, Quebec, CanadaThe case of a seven-year-old boy with chronic pruritus secondary to a giant congenital melanocytic nevus is presented. The pruritus did not respond to conventional antipruritic drug treatment, but responded to ondansetron, a selective antagonist of 5-hydroxytryptamine type 3 receptors.http://dx.doi.org/10.1155/2006/873870 |
| spellingShingle | Chantal Frigon Joëlle Desparmet Ondansetron Treatment in a Child Presenting with Chronic Intractable Pruritus Pain Research and Management |
| title | Ondansetron Treatment in a Child Presenting with Chronic Intractable Pruritus |
| title_full | Ondansetron Treatment in a Child Presenting with Chronic Intractable Pruritus |
| title_fullStr | Ondansetron Treatment in a Child Presenting with Chronic Intractable Pruritus |
| title_full_unstemmed | Ondansetron Treatment in a Child Presenting with Chronic Intractable Pruritus |
| title_short | Ondansetron Treatment in a Child Presenting with Chronic Intractable Pruritus |
| title_sort | ondansetron treatment in a child presenting with chronic intractable pruritus |
| url | http://dx.doi.org/10.1155/2006/873870 |
| work_keys_str_mv | AT chantalfrigon ondansetrontreatmentinachildpresentingwithchronicintractablepruritus AT joelledesparmet ondansetrontreatmentinachildpresentingwithchronicintractablepruritus |